Page 2 - Antech Diagnostics News Today

/PRNewswire/ -- NAVC Veterinary Meeting and Expo (VMX) booth #4222 -- Representing two decades of foundational research and a new standard of care in...

Series of three educational seminars from Mars Equestrian will explore obesity, laminitis and the senior horse, exploring relevant research and providing up-to-date nutritional advice, as well as current guidance on diagnostics.

/PRNewswire/ -- NAVC Veterinary Meeting and Expo (VMX) booth #1026 —June 6, 2021—Today, Antech Diagnostics announced new data and innovative advances to...

/PRNewswire/ -- NAVC Veterinary Meeting and Expo (VMX) booth #1026 —Today, Antech Diagnostics announced that its new Digital Cytology Scanner is available to...

/PRNewswire/ -- Antech Diagnostics has opened a new reference laboratory in Chantilly, VA, offering expanded local support to veterinarians in the metro D.C....

Shares of  The Medicines Company (NASDAQ:MDCO) [Trend Analysis] runs in leading trade, it plunging -1.81% to traded at $35.32. The firm has price volatility of 5.58% for a week and 3.71% for a month. Its beta stands at 0.49 times. The Medicines Co (MDCO) presented compelling safety and efficacy data from Day 180 interim analysis for ORION-1 Phase 2 Study of Inclisiran. The firm reported positive top-line results from the interim analysis with Day 180 follow-up for all 501 patients enrolled in...

Cats with chronic kidney disease can now live longer, better lives than ever before. “It’s been a very exciting time over the last decade or so in that we’ve really enhanced our abilities to diagnose and detect chronic kidney disease,” said Dr. Shelly L. Vaden, a professor of internal medicine at North Carolina State University College of Veterinary Medicine. “We’ve also made many improvements in medical management.” Dr. Vaden was speaking during the New Therapeutic Approaches to ...

Health your username December 10, 2020 In the Eastern District of California on Wednesday, Antech Diagnostics Inc. and Dr. Christian Leutenegger filed a complaint against Idexx Laboratories Inc., seeking declaratory relief related to threatened litigation by Idexx over trade secrets and Leutenegger’s contract with Idexx, his former employer. Leutenegger, a veterinary scientist who develops “quantitative polymerase chain reaction (qPCR or real-time PCR) tests” that primarily can detect and...